Factors Associated with Self-Reported Treatment Adherence During Pregnancy and Preliminary Psychometric Assessment of the PMAM in Primary Care.
6 affiliations
- 1Department of Urology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- 2Department of Medical Informatics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- 3Department of Family Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- 4Department of Forensic Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- 5Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- 6Faculty of Medicine, Transilvania University of Braşov, 500036 Braşov, Romania.
Abstract
Background/Objectives: Medication-taking behaviour during pregnancy may be associated with treatment-related beliefs, emotional concerns, information sources, and clinician-patient communication. We examined these cross-sectional associations and the preliminary measurement properties of the Pregnancy Medication Adherence Model (PMAM). Methods: This cross-sectional study included 355 pregnant women with prescribed treatment recruited from nine general practices in Dolj County, Romania. Q25 was analysed on its five-category scale and using an operational threshold of ≥4. Internal consistency, principal component analysis, an ordinal exploratory factor analysis based on polychoric correlations, regression modelling, and review-stage sensitivity analyses addressing criterion overlap were performed. Results: Overall, 255 participants (71.8%) scored ≥4 on Q25. The four multi-item domains had Cronbach's α values of 0.897-0.935. Parallel analysis and principal-axis factoring with oblique rotation supported four factors; salient loadings were 0.797-0.925 and no secondary loading reached 0.30. In the original adjusted binary model, cognitive understanding, emotional reassurance, clinician-patient communication, and lower endorsement of information-seeking and social-influence items were associated with Q25 ≥ 4. After Q23 was removed from the communication score and Q19 and Q24 were omitted, these four associations persisted (adjusted ORs 1.90-2.55). Conclusions: The findings identify concurrent associations between medication-related perceptions and a single self-reported treatment-behaviour item. PMAM remains an exploratory framework; external psychometric evaluation and prospective assessment against defined medication-specific adherence and clinical outcomes are required before clinical use.
Related
- Psychometric properties of the symptom and nutrition assessment questionnaire: a preliminary investigation using real-world digital health data from WellTheory
- Development and Psychometric Evaluation of the Peritoneal Dialysis Treatment Adherence Scale: A Multicenter Methodological Study.
- Content Validity and Psychometric Properties Assessment of the Virtual Reality Functional Capacity Assessment Tool and Application in Multiregional Clinical Trials of Cognitive Impairment Associated with Schizophrenia.
- Design assessment and preliminary performance evaluation of a novel device for non-invasive emergency treatment of acute respiratory failure.
- Preliminary Psychometric Evaluation of an Ultraviolet Radiation-Related Questionnaire in a Case-Control Sample
BibTeX
@article{panuș2026factors,
title = {{Factors Associated with Self-Reported Treatment Adherence During Pregnancy and Preliminary Psychometric Assessment of the PMAM in Primary Care.}},
author = {Andrei Pănuș and Virginia Maria Rădulescu and Linda Nicoleta Bărbulescu and Marian Valentin Zorilă and Kamal Adina Maria and Gheorghe Gindrovel Dumitra and Denis Anamaria Mereț and Constantin Kamal Kamal},
journal = {Healthcare (Basel, Switzerland)},
year = {2026},
month = sep,
doi = {10.3390/healthcare14193223},
url = {https://europepmc.org/article/MED/42881662},
note = {CC BY},
}
RIS
TY - JOUR
TI - Factors Associated with Self-Reported Treatment Adherence During Pregnancy and Preliminary Psychometric Assessment of the PMAM in Primary Care.
AU - Andrei Pănuș
AU - Virginia Maria Rădulescu
AU - Linda Nicoleta Bărbulescu
AU - Marian Valentin Zorilă
AU - Kamal Adina Maria
AU - Gheorghe Gindrovel Dumitra
AU - Denis Anamaria Mereț
AU - Constantin Kamal Kamal
PY - 2026
DA - 2026/09/30
JO - Healthcare (Basel, Switzerland)
DO - 10.3390/healthcare14193223
UR - https://europepmc.org/article/MED/42881662
AB - Background/Objectives: Medication-taking behaviour during pregnancy may be associated with treatment-related beliefs, emotional concerns, information sources, and clinician-patient communication. We examined these cross-sectional associations and the preliminary measurement properties of the Pregnancy Medication Adherence Model (PMAM). Methods: This cross-sectional study included 355 pregnant women with prescribed treatment recruited from nine general practices in Dolj County, Romania. Q25 was analysed on its five-category scale and using an operational threshold of ≥4. Internal consistency, principal component analysis, an ordinal exploratory factor analysis based on polychoric correlations, regression modelling, and review-stage sensitivity analyses addressing criterion overlap were performed. Results: Overall, 255 participants (71.8%) scored ≥4 on Q25. The four multi-item domains had Cronbach's α values of 0.897-0.935. Parallel analysis and principal-axis factoring with oblique rotation supported four factors; salient loadings were 0.797-0.925 and no secondary loading reached 0.30. In the original adjusted binary model, cognitive understanding, emotional reassurance, clinician-patient communication, and lower endorsement of information-seeking and social-influence items were associated with Q25 ≥ 4. After Q23 was removed from the communication score and Q19 and Q24 were omitted, these four associations persisted (adjusted ORs 1.90-2.55). Conclusions: The findings identify concurrent associations between medication-related perceptions and a single self-reported treatment-behaviour item. PMAM remains an exploratory framework; external psychometric evaluation and prospective assessment against defined medication-specific adherence and clinical outcomes are required before clinical use.
SN - 2227-9032
ER -